Audio/video for some slides is not available due to technical difficulties. CME is not offered for viewing of the recording.

Objectives

• Screen and identify patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
• Describe current disparities in care in MASLD risk, assessment, and management.
• Manage contributing risk factors to MASLD in patient care.
• Counsel patients on current risks, treatment options, and prognosis.

Presentation Slides Flyer Q&A

Speakers

Keynote Speaker

Lanla F. Conteh, MD, MPH, MBA
Director, Hepatology
Program Director, Transplant Hepatology Fellowship
The Ohio State University

Moderator

Amy Zack, MD
Case Western Reserve University